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Abstracts / Osteoarthritis and Cartilage 21 (2013) S1–S8S8and 29 weeks follow-up. Accelerated weight-bearing and rehabilitation
(8 versus 11 weeks) was demonstrated to be safe and effective at ﬁve
years following matrix autologous chondrocyte implantation for carti-
lage defects in the knee.
Conclusions: The literature search will be updated inclusive through
March 2013 and results presented.
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YEAR IN REVIEW: BIOLOGY OF OA
R.F. Loeser. Wake Forest Sch. of Med., Winston-Salem, NC, USA
The purpose of this review is to present highlights from the published
literature on the topic of the biology of OA.
A PubMed search was conducted in order to locate original research
manuscripts published since the last OARSI meeting in 2012. The search
terms osteoarthritis and/or cartilage produced over 3000 references
which were further searched for references containing both terms as
well as for terms covering other joint tissues affected by OA (meniscus,
synovium, ligaments and bone). From these common themes emerged
as active areas of research over the past year including studies in the
areas of epigenetics (in particular miRNA studies) and transcriptomics.
There appeared to be an increase from previous years in the number of
studies focused on tissues other than articular cartilage such as sub-
chondral bone, synovium and meniscus. Selected studies chosen from
the most recent publications of high relevance to OA biology will be
discussed.
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OSTEOARTHRITIS YEAR 2013 IN REVIEW: GENETICS AND GENOMICS
A. Gonzalez. Hosp. Clinico Univ.rio de Santiago, Santiago de Compostela,
Spain
Progress in the different areas of genetic research has produced
important highlights in the last year. One of wide impact is the publi-
cation of the ENCODE project. This project has analyzed transcription
and its regulation, including epigenetic marks and transcription factors,
in multiple cell lines across the genome. The results have shown the
impressive complexity of the works of the human genome and have
provided us with a wealth of data that will accelerate research in all
aspects of genetics. More speciﬁc of OA has been the discovery of new
loci associated with OA: a dozen loci with genome wide signiﬁcant
association in Europeans or Asians are already known, with others
showing promising results. New additions include the ﬁve loci identi-
ﬁed in the arcOGEN GWAS and other loci resulting frommetaanalysis of
multiple GWAS and additional sample collections. These discoveries
have shown the value of large sample sizes for association studies and
of the investigation of OA endophenotypes. They have also provided
solid information on a much discussed issue, the relative difﬁculty of
ﬁnding loci in OA and its relationship with OA phenotype heterogeneity
or with misclassiﬁcation of controls. The arcOGEN list of discoveries
includes two good candidate genes: CHST11 coding for the enzyme
attaching sulfate to the N-acetylgalactosamines of chondroitin sulfate 4,
and PTHLH, which is an established regulator of chondrocyte differen-
tiation and skeletogenesis. Functional studies of OA loci continue
deﬁning their involvement in OA by exploring their expression and
downstream effects in joint tissues. Previous studies have analyzed the
six genes contained in the 7q22 locus and reached different conclusions
about which of them is the most likely candidate. This year, a new
report supports HBP1 over the other ﬁve genes based on differential
allele expression in joint tissues. MicroRNA studies have continued to
expand the list of joint changes and OA phenotypes that are controlled
by this wide family of post-transcriptional regulators. The variety of
results makes them difﬁcult to summarize, but they show the ubiqui-
tous participation of microRNAs in all aspects of OA. A different type of
small non-coding RNA, the small nucleolar RNAs U38 and U48, havemade their surprising debut in OA as serum biomarkers of cartilage
damage. Analysis of DNA methylation in the promoters of NOS2 (iNOS)
and SOX9 has provided more evidence of the importance of this
epigenetic modiﬁcation in OA. These studies add new layers of
complexity to our knowledge of OA biology. Gene expression micro-
array studies have addressed differences between hip and knee OA,
between growth plate and articular cartilage, and between Kashin-Beck
disease and OA. All these last year results together with ongoing
collaborative projects and technical developments predict an acceler-
ated progress in all areas of OA genetics for the coming months.
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OSTEOARTHRITIS YEAR 2013 IN REVIEW: BIOMARKERS; ARE WE
MAKING STEPS AHEAD?
F. Lafeber, E. Van Spil. UMC Utrecht, Utrecht, Netherlands
In 2010, in Osteoarthritis and Cartilage (van Spil WE et al.), we published
a comprehensive systematic review applying the consensus BIPED
criteria on serum and urinary biochemical markers for knee and hip
osteoarthritis (OA) that were available at that time. It was concluded
that none of the biochemical markers at that time was sufﬁciently
discriminating to aid to diagnosis and prognosis of OA in individuals or
limited numbers of patients, or performed so consistently that it could
function as an outcome in clinical trials. It was suggested that more
research on molecular validation and the origins and metabolism of
biochemical markers would be necessary. Also, wide-spectrum
biochemical marker analysis in well-deﬁned populations, preferably
with protocolised sample collection, was considered valuable. Together
this would clarify many unknowns about biochemical markers that
hampers progression of the ﬁeld.
At present, more than 2 years later, in this ‘year in review’ on
biomarkers of OAwewill discuss the progress that has beenmade in the
ﬁeld ever since. And, in all modesty, we will try to recommend on how
the ﬁeld may reach the ultimate goal of having proper biochemical
markers that can serve as diagnostic, prognostic, and/or monitoring
tools.
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OSTEOARTHRITIS YEAR IN REVIEW: IMAGING
T.J. Mosher. Penn State Univ., Hershey, PA, USA
Purpose: To review recent original research publications related to
imaging of osteoarthritis and identify emerging trends and signiﬁcant
advances.
Methods: To identify relevant articles an extensive search was per-
formed of the PubMed database using the query terms “osteoarthritis”
in combination with “imaging”, “radiography”, “MRI”, “ultrasound”,
“computed tomography”, “nuclear medicine” for articles published or in
press between April 2012 and January 2013. Abstracts were reviewed to
exclude review articles, case reports, and studies not focused on
imaging using routine clinical imaging measures.
Results: Initial query yielded 932 references which were reduced to
328 citations following the initial review. MRI (118 references) and
radiography (129 refs) remain the primary imaging modalities in OA
studies, with growth in application of CT (35 refs) and ultrasound
(23 refs). MRI parametric mapping techniques remain an active
research area (33 refs) with growth in T2*- and T1rho mapping
publications. Although the knee is the major joint studied (210 refs)
there is growing interest in the hip (106 refs) and hand (29 refs).
Imaging continues to focus on evaluation of cartilage (173 refs) and
bone (119 refs).
Conclusions: Imaging plays a major role in osteoarthritis research with
continued growth along traditional lines of investigation. Emerging
trends are application of advanced MRI techniques in the study of the
hip and growth in quantitative methods for evaluating changes in bone.
